Key result
A combination of array comparative genomic hybridization and sequence analysis successfully identified known DMD mutations in all 6 patients and provided a molecular diagnosis in 7 of 8 untested individuals.
A combination of aCGH and sequence analysis provides a streamlined and effective protocol for detecting DMD gene mutations in a diagnostic laboratory setting.
Answers are grounded in this paper and cite their sources.
May support combined aCGH/sequencing for DMD diagnostics in small cohorts; leaves open larger validation before routine lab adoption.
Purpose. The aim of this study was to develop a streamlined mutation screening protocol for the DMD gene in order to confirm a clinical diagnosis of Duchenne or Becker muscular dystrophy in affected males and to clarify the carrier status of female family members. Methods. Sequence analysis and array comparative genomic hybridization (aCGH) were used to identify mutations in the dystrophin DMD gene. We analysed genomic DNA from six individuals with a range of previously characterised mutations and from eight individuals who had not previously undergone any form of molecular analysis. Results. We successfully identified the known mutations in all six patients. A molecular diagnosis was also made in three of the four patients with a clinical diagnosis who had not undergone prior genetic screening, and testing for familial mutations was successfully completed for the remaining four patients. Conclusion. The mutation screening protocol described here meets best practice guidelines for molecular testing of the DMD gene in a diagnostic laboratory. The aCGH method is a superior alternative to more conventional assays such as multiplex ligation-dependent probe amplification (MLPA). The combination of aCGH and sequence analysis will detect mutations in 98% of patients with the Duchenne or Becker muscular dystrophy.
No takes yet. Share an insight, caveat, or question.
Marquis‐Nicholson et al. (2013) studied Duchenne or Becker muscular dystrophy (n=14). Array comparative genomic hybridization (aCGH) and bidirectional sequence analysis was evaluated on Identification of mutations in the DMD gene. A combination of array comparative genomic hybridization and sequence analysis successfully identified known DMD mutations in all 6 patients and provided a molecular diagnosis in 7 of 8 untested individuals.
Synapse has enriched 10 related papers. Consider them for comparative context: